कोशिश गोल्ड - मुक्त
Cabinet approves major expansion of PG and UG medical education capacity
Bio Spectrum
|December 2025
Union Cabinet chaired by the Prime Minister Narendra Modi has approved the Phase-Ill of the Centrally Sponsored Scheme (CSS) for strengthening and upgradation of existing State Government/ Central Government Medical Colleges/Standalone PG Institutes/ Government Hospitals for increasing 5,000 PG seats and extension of the CSS for upgradation of existing government medical colleges for increasing 5,023 MBBS seats with an enhanced cost ceiling of Rs 1.5 crore per seat.
-
This initiative will significantly augment the undergraduate medical capacity; availability of specialist doctors by creating additional postgraduate seats; an
यह कहानी Bio Spectrum के December 2025 संस्करण से ली गई है।
हजारों चुनिंदा प्रीमियम कहानियों और 10,000 से अधिक पत्रिकाओं और समाचार पत्रों तक पहुंचने के लिए मैगज़्टर गोल्ड की सदस्यता लें।
क्या आप पहले से ही ग्राहक हैं? साइन इन करें
Bio Spectrum से और कहानियाँ
Bio Spectrum
Biotium's new cell barcoding kit streamlines flow cytometry with single-tube multiplexing
Biotium, a leading provider of fluorescent reagents and kits for life science research, has announced the release of the ViaPlex 2-Color Cell Barcoding Kit.
1 min
May 2026
Bio Spectrum
NATHEALTH names Dr Sangita Reddy as new President
NATHEALTH, an apex body representing the Indian healthcare industry, has announced Dr Sangita Reddy, Joint Managing Director, Apollo Hospitals Group, as its new President for FY 2026-2027.
1 min
May 2026
Bio Spectrum
Rs 4.51 Lakh Crore Health Push: How State Budgets Are Powering India's Next Healthcare Leap
In recent years, state health budgets have transformed from simple financial documents into strategic instruments for improving healthcare outcomes.
7 mins
May 2026
Bio Spectrum
WHO lays focus on simulation exercises to strengthen health emergency readiness
To support countries to prepare more systematically against emergencies, WHO has recently released new global guidance which enables countries to move beyond oneoff emergency drills and establish National Health Simulation Exercise Programmes (NHSEP).
1 min
May 2026
Bio Spectrum
Akrivia Biosciences decodes breast cancer genomic heterogeneity
Akrivia Biosciences, a cancer genomics startup based in London and Mumbai, has announced a foundational scientific breakthrough that uncovers hidden organisation of cancer genomes, successfully decoding breast cancer genomic heterogeneity, a major bottleneck that has historically hindered the comprehensive understanding of tumour biology in patients.
1 min
May 2026
Bio Spectrum
Integrating AI for Tech-driven Ayurveda
A promising trend emerging in 2026 is the integration of artificial intelligence (AI) into ayurveda, to not only make ayurveda more accessible and scalable but to also create opportunities to back up ayurveda with science and technology.
2 mins
May 2026
Bio Spectrum
ASPIRE BIONEST signs MoU with Indian Immunologicals to advance One Health Innovation
ASPIRE BIONEST, a life sciences incubation centre at the University of Hyderabad, has signed a strategic Memorandum of Understanding (MoU) with Indian Immunologicals Ltd. (IIL), a leading vaccine-focused biotechnology company, to advance innovation under the One Health framework.
1 min
May 2026
Bio Spectrum
MSD India and Smile Foundation award 50 scholarships to aspiring pharmacy students
MSD (known as Merck & Co., Inc., Rahway, N.J., USA in the United States and Canada) in India has announced the awarding of scholarships to 50 students under its corporate social responsibility initiative 'Scholarship for Daughters' programme, a merit-based initiative aimed at supporting young women from underserved communities to pursue a Bachelor of Pharmacy degree at select accredited pharmacy colleges across India.
1 min
May 2026
Bio Spectrum
Thermo Fisher launches integrated platform to accelerate biologics development
Thermo Fisher Scientific Inc. has announced a next-generation, integrated cell line development platform that enables biologics developers to accelerate time to clinic while maintaining regulatory confidence and commercial scalability.
1 min
May 2026
Bio Spectrum
Eurofins Viracor unveils ExPECT anti-CD19 (obe-cel) CAR T-cell assay
Eurofins Viracor, a leader in advanced clinical diagnostics, has announced the launch of the ExPECT anti-CD19 (obe-cel) CAR T-cell assay, a cutting-edge solution designed to help clinicians monitor CAR T-cell therapy performance with validated precision and a quick turn-around-time for results.
1 min
May 2026
Listen
Translate
Change font size

